Fluocinonide has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids may cause systemic effects in the mother, it is unlikely that short-term application of topical corticosteroids would pose a risk to the breastfed infant by passage into breastmilk. However, it would be prudent to use the least potent drug on the smallest area of skin possible. It is particularly important to ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated. Only the lower potency corticosteroids should be used on the nipple or areola where the infant could directly ingest the drugs from the skin; fluocinonide should be avoided on the nipple.[1] Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.[2] Any topical corticosteroid should be wiped off thoroughly prior to nursing if it is being applied to the breast or nipple area.
尚未对哺乳期使用氟轻松奈德进行研究。由于只有广泛应用最强效的皮质类固醇才可能对母亲产生全身影响，因此局部应用皮质类固醇短期使用不太可能因进入母乳而对母乳喂养的婴儿构成风险。然而，尽可能在最小面积的皮肤上使用最低效的药物是谨慎的做法。特别重要的是要确保婴儿的皮肤不与已治疗的皮肤区域直接接触。仅应在婴儿可能直接从皮肤上摄入药物的乳头或乳晕上使用低效皮质类固醇；应避免在乳头上使用氟轻松奈德。[1] 仅应将与水可混溶的乳膏或凝胶产品应用于乳房，因为软膏可能会使婴儿通过舔舐接触到高含量的矿物石蜡。[2] 如果将任何局部皮质类固醇应用于乳房或乳头区域，在哺乳前应彻底擦拭干净。
